<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04673877</url>
  </required_header>
  <id_info>
    <org_study_id>20-007132</org_study_id>
    <nct_id>NCT04673877</nct_id>
  </id_info>
  <brief_title>Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration</brief_title>
  <official_title>Tissue Concentrations of Vancomycin Achieved With Bier Block Administration Versus Intravenous Prophylaxis in Upper Extremity Surgery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether or not giving a lower dose of antibiotics&#xD;
      (Vancomycin) in the area where it is needed (upper extremity) is more effective at preventing&#xD;
      infection than the current standard dose which is given intravenously (IV).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 26, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tissue concentrations of vancomycin</measure>
    <time_frame>Approximately 45-60 minutes after skin incision</time_frame>
    <description>Tissue concentrations of vancomycin in the hand and wrist following Bier Block administration versus systemic IV administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>Number of adverse events reported for Bier Block administered vancomycin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Infection</condition>
  <condition>Hand Injury Wrist</condition>
  <condition>Hand Injuries</condition>
  <condition>Hand Injuries and Disorders</condition>
  <condition>Hand Arthritis</condition>
  <arm_group>
    <arm_group_label>Bier Block Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive antibiotic Vancomycin from a Bier Block (injected into an arm vein with a tourniquet up to keep antibiotics in the arm). Samples will be collected from bone and tissue that is normally removed during surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic Intravenous IV Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive antibiotic Vancomycin through intravenous administration. Samples will be collected from bone and tissue that is normally removed during during surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Systemic IV Vancomycin</intervention_name>
    <description>1 g of vancomycin will be delivered intravenously over a period of one hour prior to tourniquet inflation.</description>
    <arm_group_label>Systemic Intravenous IV Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bier Block</intervention_name>
    <description>After exsanguination of the limb and elevation of the tourniquet in the prepped and draped patient, Vancomycin will be injected into a superficial vein in the hand, wrist or forearm.</description>
    <arm_group_label>Bier Block Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin</intervention_name>
    <description>500 mg diluted in 50 cc normal saline of injection into superficial vein in the hand, wrist or forearm</description>
    <arm_group_label>Bier Block Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing upper extremity reconstruction by a single surgeon.&#xD;
&#xD;
          -  Surgical cases will include:&#xD;
&#xD;
               -  Trapeziectomy/suspensionplasty.&#xD;
&#xD;
               -  PIPJ/MPJ arthroplasty.&#xD;
&#xD;
               -  Proximal row carpectomy.&#xD;
&#xD;
               -  Distal ulnar resection.&#xD;
&#xD;
               -  Distal radius fracture fixation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to adequately cannulate a superficial vein in the upper extremity within 5&#xD;
             minutes of tourniquet inflation.&#xD;
&#xD;
          -  Evidence of subcutaneous extravasation in Bier block group.&#xD;
&#xD;
          -  History of renal dysfunction.&#xD;
&#xD;
          -  Vancomycin allergy.&#xD;
&#xD;
          -  ASA&gt;/= 3.&#xD;
&#xD;
          -  History of lung cancer.&#xD;
&#xD;
          -  Known HIV infection.&#xD;
&#xD;
          -  History of organ transplantation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Renfree, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 26, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kevin J. Renfree</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Hand Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 23, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT04673877/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

